Literature DB >> 11417858

RAG1 and RAG2 in V(D)J recombination and transposition.

S D Fugmann1.   

Abstract

RAG1 and RAG2 are the key components of the V(D)J recombinase machinery that catalyses the somatic gene rearrangements of antigen receptor genes during lymphocyte development. In the first step of V(D)J recombination--DNA cleavage--the RAG proteins act together as an endonuclease to excise the DNA between two individual gene segments. They are also thought to be involved in the subsequent DNA joining step. In vitro, the RAG proteins catalyze the integration of the excised DNA element into target DNA completing a process similar to bacterial transposition. In vivo, this reaction is suppressed by an unknown mechanism. The individual roles of RAG1 and RAG2 in V(D)J recombination and transposition reactions are discussed based on mutation analyses and structure predictions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11417858     DOI: 10.1385/IR:23:1:23

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  100 in total

1.  Mutational analysis of RAG1 and RAG2 identifies three catalytic amino acids in RAG1 critical for both cleavage steps of V(D)J recombination.

Authors:  M A Landree; J A Wibbenmeyer; D B Roth
Journal:  Genes Dev       Date:  1999-12-01       Impact factor: 11.361

Review 2.  DNA end-joining: from yeast to man.

Authors:  S E Critchlow; S P Jackson
Journal:  Trends Biochem Sci       Date:  1998-10       Impact factor: 13.807

3.  Dual role of RAG2 in V(D)J recombination: catalysis and regulation of ordered Ig gene assembly.

Authors:  S A Kirch; G A Rathbun; M A Oettinger
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

4.  RAG1 and RAG2 form a stable postcleavage synaptic complex with DNA containing signal ends in V(D)J recombination.

Authors:  A Agrawal; D G Schatz
Journal:  Cell       Date:  1997-04-04       Impact factor: 41.582

5.  Specific recognition of cruciform DNA by nuclear protein HMG1.

Authors:  M E Bianchi; M Beltrame; G Paonessa
Journal:  Science       Date:  1989-02-24       Impact factor: 47.728

6.  RAG-2 promotes heptamer occupancy by RAG-1 in the assembly of a V(D)J initiation complex.

Authors:  P C Swanson; S Desiderio
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

Review 7.  Tn10 and IS10 transposition and chromosome rearrangements: mechanism and regulation in vivo and in vitro.

Authors:  N Kleckner; R M Chalmers; D Kwon; J Sakai; S Bolland
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

Review 8.  The mechanism of V(D)J joining: lessons from molecular, immunological, and comparative analyses.

Authors:  S M Lewis
Journal:  Adv Immunol       Date:  1994       Impact factor: 3.543

9.  The V(D)J recombination activating gene, RAG-1.

Authors:  D G Schatz; M A Oettinger; D Baltimore
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

10.  Functional analysis of coordinated cleavage in V(D)J recombination.

Authors:  D R Kim; M A Oettinger
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

View more
  11 in total

1.  Genomic regions exhibiting positive selection identified from dense genotype data.

Authors:  Christopher S Carlson; Daryl J Thomas; Michael A Eberle; Johanna E Swanson; Robert J Livingston; Mark J Rieder; Deborah A Nickerson
Journal:  Genome Res       Date:  2005-11       Impact factor: 9.043

2.  Noncore RAG1 regions promote Vβ rearrangements and αβ T cell development by overcoming inherent inefficiency of Vβ recombination signal sequences.

Authors:  Julie E Horowitz; Craig H Bassing
Journal:  J Immunol       Date:  2014-01-10       Impact factor: 5.422

3.  In vivo transposition mediated by V(D)J recombinase in human T lymphocytes.

Authors:  Terri L Messier; J Patrick O'Neill; Sai-Mei Hou; Janice A Nicklas; Barry A Finette
Journal:  EMBO J       Date:  2003-03-17       Impact factor: 11.598

4.  Modeling altered T-cell development with induced pluripotent stem cells from patients with RAG1-dependent immune deficiencies.

Authors:  Patrick M Brauer; Itai M Pessach; Erik Clarke; Jared H Rowe; Lisa Ott de Bruin; Yu Nee Lee; Carmen Dominguez-Brauer; Anne M Comeau; Geneve Awong; Kerstin Felgentreff; Yuhang H Zhang; Andrea Bredemeyer; Waleed Al-Herz; Likun Du; Francesca Ververs; Marion Kennedy; Silvia Giliani; Gordon Keller; Barry P Sleckman; David G Schatz; Frederic D Bushman; Luigi D Notarangelo; Juan Carlos Zúñiga-Pflücker
Journal:  Blood       Date:  2016-06-14       Impact factor: 22.113

5.  A hypomorphic Artemis human disease allele causes aberrant chromosomal rearrangements and tumorigenesis.

Authors:  Cheryl Jacobs; Ying Huang; Tehmina Masud; William Lu; Gerwin Westfield; William Giblin; JoAnn M Sekiguchi
Journal:  Hum Mol Genet       Date:  2010-12-08       Impact factor: 6.150

Review 6.  Role of recombination activating genes in the generation of antigen receptor diversity and beyond.

Authors:  Mayilaadumveettil Nishana; Sathees C Raghavan
Journal:  Immunology       Date:  2012-12       Impact factor: 7.397

7.  A novel missense RAG-1 mutation results in T-B-NK+ SCID in Athabascan-speaking Dine Indians from the Canadian Northwest Territories.

Authors:  Zheng Xiao; Steven M Yannone; Elizabeth Dunn; Morton J Cowan
Journal:  Eur J Hum Genet       Date:  2008-08-13       Impact factor: 4.246

8.  The effect of CRISPR constructs microinjection on the expression of developmental genes in Rag1 knocked-out mice embryo.

Authors:  Maryam Salimi; Abolfazl Shirazi; Koushan Sineh Sepehr; Mohsen Norouzian; Vahid Ebrahimi; Maryam Mehravar; Mohammad Majidi; Mohammad M Mehrazar
Journal:  Vet Med Sci       Date:  2021-05-06

9.  The activation-induced deaminase functions in a postcleavage step of the somatic hypermutation process.

Authors:  F Nina Papavasiliou; David G Schatz
Journal:  J Exp Med       Date:  2002-05-06       Impact factor: 14.307

10.  Impact of a hypomorphic Artemis disease allele on lymphocyte development, DNA end processing, and genome stability.

Authors:  Ying Huang; William Giblin; Martina Kubec; Gerwin Westfield; Jordan St Charles; Laurel Chadde; Stephanie Kraftson; JoAnn Sekiguchi
Journal:  J Exp Med       Date:  2009-04-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.